Apr 11, 2011 | Posted by: roboblogger
Main Category: Respiratory / Asthma Also Included In: Clinical Trials / Drug Trials Article Date: 11 Apr 2011 APEPTICO, a privately-held biotechnology company developing peptide drugs based on its PEPBASE discovery technology, today announced the initiation of a Phase I clinical trial with its lead product AP301 to assess the safety and ...
Comments
|
Winnipeg, Canada |
Why is all this Pharma propaganda being posted for?
|
|
Tell me when this thread is updated: |
|
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
|
|
Apr 26 | Anonymous | 1 |
|
|
Apr '13 | Freedomtobeme | 1 |
|
|
Mar '13 | Who | 1 |
|
|
Feb '13 | piv | 1 |
|
|
Jan '13 | Sheik Yerbouti | 2 |
|
|
Nov '12 | Anonymous | 2 |
|
|
Oct '12 | michael lewendon | 2 |